321 related articles for article (PubMed ID: 8690900)
1. IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes.
Romano MF; Lamberti A; Petrella A; Bisogni R; Tassone PF; Formisano S; Venuta S; Turco MC
J Immunol; 1996 Mar; 156(6):2119-23. PubMed ID: 8690900
[TBL] [Abstract][Full Text] [Related]
2. Regulation of NF-kappa B nuclear activity in peripheral blood mononuclear cells: role of CD28 antigen.
Romano MF; Bisogni R; Lamberti A; Turco MC; Petrella A; Tassone P; Van Lier R; Formisano S; Venuta S
Cell Immunol; 1994 Jul; 156(2):371-7. PubMed ID: 8025954
[TBL] [Abstract][Full Text] [Related]
3. Long-term inositol phosphate release, but not tyrosine kinase activity, correlates with IL-2 secretion and NF-AT induction in anti-CD3-activated peripheral human T lymphocytes.
Bryan RG; Li Y; Totten RK; Van M; Tan TH; Rich RR
Cell Immunol; 1994 Aug; 157(1):158-69. PubMed ID: 8039243
[TBL] [Abstract][Full Text] [Related]
4. Activation of primary human T-lymphocytes through CD2 plus CD28 adhesion molecules induces long-term nuclear expression of NF-kappa B.
Costello R; Lipcey C; Algarté M; Cerdan C; Baeuerle PA; Olive D; Imbert J
Cell Growth Differ; 1993 Apr; 4(4):329-39. PubMed ID: 8098618
[TBL] [Abstract][Full Text] [Related]
5. The role of NF-kappa B1 (p50/p105) gene expression in activation of human blood T-lymphocytes via CD2 and CD28 adhesion molecules.
Costello R; Cerdan C; Lipcey C; Algarté M; Martin Y; Baeuerle PA; Olive D; Imbert J
Cell Growth Differ; 1993 Nov; 4(11):947-54. PubMed ID: 7905283
[TBL] [Abstract][Full Text] [Related]
6. Regulation of nuclear factor-kappa B and activator protein-1 activities after stimulation of T cells via glycosylphosphatidylinositol-anchored Ly-6A/E.
Ivanov V; Fleming TJ; Malek TR
J Immunol; 1994 Sep; 153(6):2394-406. PubMed ID: 7915738
[TBL] [Abstract][Full Text] [Related]
7. Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression.
Wong HK; Kammer GM; Dennis G; Tsokos GC
J Immunol; 1999 Aug; 163(3):1682-9. PubMed ID: 10415075
[TBL] [Abstract][Full Text] [Related]
8. Biphasic control of nuclear factor-kappa B activation by the T cell receptor complex: role of tumor necrosis factor alpha.
Pimentel-Muiños FX; Mazana J; Fresno M
Eur J Immunol; 1995 Jan; 25(1):179-86. PubMed ID: 7843230
[TBL] [Abstract][Full Text] [Related]
9. Alpha 4 beta 1 (CD49d/CD29) integrin costimulation of human T cells enhances transcription factor and cytokine induction in the absence of altered sensitivity to anti-CD3 stimulation.
Udagawa T; Woodside DG; McIntyre BW
J Immunol; 1996 Sep; 157(5):1965-72. PubMed ID: 8757316
[TBL] [Abstract][Full Text] [Related]
10. Age-related decreases in IL-2 production by human T cells are associated with impaired activation of nuclear transcriptional factors AP-1 and NF-AT.
Whisler RL; Beiqing L; Chen M
Cell Immunol; 1996 May; 169(2):185-95. PubMed ID: 8620546
[TBL] [Abstract][Full Text] [Related]
11. Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines.
Pimentel-Muiños FX; Muñoz-Fernández MA; Fresno M
J Immunol; 1994 Jun; 152(12):5714-22. PubMed ID: 8207202
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells.
Marienfeld R; Neumann M; Chuvpilo S; Escher C; Kneitz B; Avots A; Schimpl A; Serfling E
Eur J Immunol; 1997 Jul; 27(7):1601-9. PubMed ID: 9247567
[TBL] [Abstract][Full Text] [Related]
13. Deficient translocation of c-Rel is associated with impaired Th1 cytokine production in T cells from atopic dermatitis patients.
Dieckhoff K; Graf P; Beinhauer B; Schwaerzler C; Carballido JM; Neumann C; Zachmann K; Jung T
Exp Dermatol; 2005 Jan; 14(1):17-25. PubMed ID: 15660915
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
[TBL] [Abstract][Full Text] [Related]
15. Interaction of HIV gp120 and anti-CD4 antibodies with the CD4 molecule on human CD4+ T cells inhibits the binding activity of NF-AT, NF-kappa B and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity.
Jabado N; Le Deist F; Fisher A; Hivroz C
Eur J Immunol; 1994 Nov; 24(11):2646-52. PubMed ID: 7957556
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor-kappa B in signal conduction of protein kinase C in T lymphocytes from an asthmatic guinea pig model.
Xiong W; Xu Y; Zhang Z; Wang X; Mo B; Fu J
Chin Med J (Engl); 2002 May; 115(5):685-9. PubMed ID: 12133535
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
McGuire KL; Iacobelli M
J Immunol; 1997 Aug; 159(3):1319-27. PubMed ID: 9233628
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin A inhibits the early phase of NF-kappaB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells.
Nishiyama S; Manabe N; Kubota Y; Ohnishi H; Kitanaka A; Tokuda M; Taminato T; Ishida T; Takahara J; Tanaka T
Int Immunopharmacol; 2005 Apr; 5(4):699-710. PubMed ID: 15710339
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific regulation of IL-6 production by IL-4. Differential effects of IL-4 on nuclear factor-kappa B activity in monocytes and fibroblasts.
Donnelly RP; Crofford LJ; Freeman SL; Buras J; Remmers E; Wilder RL; Fenton MJ
J Immunol; 1993 Nov; 151(10):5603-12. PubMed ID: 8228249
[TBL] [Abstract][Full Text] [Related]
20. The transcriptionally active factors mediating the effect of the HTLV-I Tax transactivator on the IL-2R alpha kappa B enhancer include the product of the c-rel proto-oncogene.
Crenon I; Béraud C; Simard P; Montagne J; Veschambre P; Jalinot P
Oncogene; 1993 Apr; 8(4):867-75. PubMed ID: 8455941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
